-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

clonoSEQ and MRD Assessment in the Management of Lymphoid Malignancies

Sponsor: Adaptive Biotechnologies
Program: Product Theaters
Monday, December 7, 2020: 10:30 AM-11:30 AM
clonoSEQ and MRD Assessment in the Management of Lymphoid Malignancies

Lanny R. Kirsch, MD

Adaptive Biotechnologies, Seattle, WA
See more of: Product Theaters
<< Previous Product Theater | Next Product Theater >>